WJOG5208L_2B: WJOG5208L, figure 2B

WJOG5208L_2BR Documentation

WJOG5208L, figure 2B

Description

Kaplan-Meier digitized data from WJOG5208L, figure 2B (PMID 26522337). A reported sample size of 355 for a primary endpoint of OS in lung cancer.

Usage

WJOG5208L_2B

Format

A data frame of 349 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (cisplatin_docetaxel, nedaplatin_docetaxel)

Source

Shukuya T, Yamanaka T, Seto T, et al. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial. Lancet Oncol 2015; 16: 1630–8.

Examples

summary(WJOG5208L_2B)

kmplot(WJOG5208L_2B)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.